Literature DB >> 9682040

Rate of pregnancy-related relapse in multiple sclerosis. Pregnancy in Multiple Sclerosis Group.

C Confavreux1, M Hutchinson, M M Hours, P Cortinovis-Tourniaire, T Moreau.   

Abstract

BACKGROUND AND METHODS: Multiple sclerosis often occurs in young women, and the effect of pregnancy on the disease is poorly understood. We studied 254 women with multiple sclerosis during 269 pregnancies in 12 European countries. The women were followed during their pregnancies and for up to 12 months after delivery to determine the rate of relapse per trimester and the score on the Kurtzke Expanded Disability Status Scale (range, 0 to 10, with higher scores indicating more severe disability). The relapse rate in each trimester was compared with the rate during the year before the pregnancy. The effects of epidural analgesia and breast-feeding on the frequency of relapse during the first three months post partum and the disability score at 12 months post partum were also determined.
RESULTS: The mean (+/-SD) rate of relapse was 0.7+/-0.9 per woman per year in the year before pregnancy; it was 0.5+/-1.3 during the first trimester (P=0.03 for the comparison with the rate before pregnancy), 0.6+/-1.6 during the second trimester (P=0.17), and 0.2+/-1.0 during the third (P<0.001). The rate increased to 1.2+/-2.0 during the first three months post partum (P<0.001) and then returned to the prepregnancy rate. The mean Kurtzke disability score worsened by 0.7 point during 33 months of follow-up, with no apparent acceleration during the post-partum period. Neither breast-feeding nor epidural analgesia had an adverse effect on the rate of relapse or on the progression of disability in multiple sclerosis.
CONCLUSIONS: In women with multiple sclerosis, the rate of relapse declines during pregnancy, especially in the third trimester, and increases during the first three months post partum before returning to the prepregnancy rate.

Entities:  

Mesh:

Year:  1998        PMID: 9682040     DOI: 10.1056/NEJM199807303390501

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  305 in total

Review 1.  The genetic epidemiology of multiple sclerosis.

Authors:  A Compston
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1999-10-29       Impact factor: 6.237

2.  Toxoplasmosis.

Authors: 
Journal:  Can Fam Physician       Date:  1999-12       Impact factor: 3.275

Review 3.  Effect of pregnancy and obstructive jaundice on inflammatory diseases: the work of P S Hench revisited.

Authors:  I Crocker; N Lawson; J Fletcher
Journal:  Ann Rheum Dis       Date:  2002-04       Impact factor: 19.103

4.  Estrogen protection against EAE modulates the microbiota and mucosal-associated regulatory cells.

Authors:  Gil Benedek; Jun Zhang; Ha Nguyen; Gail Kent; Hilary A Seifert; Sean Davin; Patrick Stauffer; Arthur A Vandenbark; Lisa Karstens; Mark Asquith; Halina Offner
Journal:  J Neuroimmunol       Date:  2017-06-21       Impact factor: 3.478

5.  Management of pregnancy-related issues in multiple sclerosis patients: the need for an interdisciplinary approach.

Authors:  Maria Pia Amato; Antonio Bertolotto; Roberto Brunelli; Paola Cavalla; Benedetta Goretti; Maria Giovanna Marrosu; Francesco Patti; Carlo Pozzilli; Leandro Provinciali; Nicola Rizzo; Nicola Strobelt; Gioacchino Tedeschi; Maria Trojano; Giancarlo Comi
Journal:  Neurol Sci       Date:  2017-08-02       Impact factor: 3.307

6.  Lower brain diffusivity in postpartum period compared to late pregnancy: results from a prospective imaging study of multiple sclerosis patients.

Authors:  Teemu Paavilainen; Timo Kurki; Markus Färkkilä; Oili Salonen; Riitta Parkkola; Laura Airas
Journal:  Neuroradiology       Date:  2011-12-13       Impact factor: 2.804

Review 7.  Pregnancy and pregnancy-associated hormones alter immune responses and disease pathogenesis.

Authors:  Dionne P Robinson; Sabra L Klein
Journal:  Horm Behav       Date:  2012-03-03       Impact factor: 3.587

Review 8.  Specific aspects of modern life for people with multiple sclerosis: considerations for the practitioner.

Authors:  Celia Oreja-Guevara; Heinz Wiendl; Bernd C Kieseier; Laura Airas
Journal:  Ther Adv Neurol Disord       Date:  2014-03       Impact factor: 6.570

9.  Membrane estrogen receptor regulates experimental autoimmune encephalomyelitis through up-regulation of programmed death 1.

Authors:  Chunhe Wang; Babak Dehghani; Yuexin Li; Laurie J Kaler; Thomas Proctor; Arthur A Vandenbark; Halina Offner
Journal:  J Immunol       Date:  2009-03-01       Impact factor: 5.422

10.  Pregnancy-related relapses and breastfeeding in a contemporary multiple sclerosis cohort.

Authors:  Annette Langer-Gould; Jessica B Smith; Kathleen B Albers; Anny H Xiang; Jun Wu; Erica H Kerezsi; Keeli McClearnen; Edlin G Gonzales; Amethyst D Leimpeter; Stephen K Van Den Eeden
Journal:  Neurology       Date:  2020-04-13       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.